Camptosar - 0009-7529-05 - (IRINOTECAN HYDROCHLORIDE)

Alphabetical Index


Drug Information of Camptosar

Product NDC: 0009-7529
Proprietary Name: Camptosar
Non Proprietary Name: IRINOTECAN HYDROCHLORIDE
Active Ingredient(s): 20    mg/mL & nbsp;   IRINOTECAN HYDROCHLORIDE
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Camptosar

Product NDC: 0009-7529
Labeler Name: Pharmacia and Upjohn Company
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020571
Marketing Category: NDA
Start Marketing Date: 19960614

Package Information of Camptosar

Package NDC: 0009-7529-05
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-05) > 15 mL in 1 VIAL, SINGLE-DOSE

NDC Information of Camptosar

NDC Code 0009-7529-05
Proprietary Name Camptosar
Package Description 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-05) > 15 mL in 1 VIAL, SINGLE-DOSE
Product NDC 0009-7529
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name IRINOTECAN HYDROCHLORIDE
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19960614
Marketing Category Name NDA
Labeler Name Pharmacia and Upjohn Company
Substance Name IRINOTECAN HYDROCHLORIDE
Strength Number 20
Strength Unit mg/mL
Pharmaceutical Classes Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]

Complete Information of Camptosar


General Information